IP Library Granted Patent US 11,278,665
Granted Patent B2
US 11,278,665 · App. 16/462,458 · Granted Mar 22, 2022

Method for delivering a therapeutic substance

Inventors: Shahar Zidon (Kibbutz Shefayim, IL); Boaz Eitan (Hofit, IL); Ori Ben-David (Tel Aviv, IL); Andrei Yosef (Even Yehuda, IL)
Assignee: EITAN MEDICAL LTD.
A61M5/14216A61M5/14248A61M5/16809A61M5/16827A61M2005/14208
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,665
App. No.
16/462,458
Granted
Mar 22, 2022
Kind
B2
Abstract

Apparatus is provided including a therapeutic substance reservoir ( 24 ) configured to hold a therapeutic substance ( 22 ), and an electromechanical pumping assembly ( 26 ). The pumping assembly is shaped to define a pump chamber ( 28 ) having (a) a therapeutic substance inlet ( 30 ), and (b) a therapeutic substance outlet ( 32 ). The pumping assembly includes a plunger ( 34 ) disposed such that therapeutic substance in the pump chamber is in direct contact with the plunger, and control circuitry ( 36 ) configured to drive the plunger to (a) draw the therapeutic substance into the pump chamber during a first pumping phase, and (b) deliver the therapeutic substance from the pump chamber in a plurality of discrete motions of the plunger during a second pumping phase.

Claims (14)

1. A method of delivering a therapeutic substance to a subject, the method comprising:

using a plunger to draw the therapeutic substance from a therapeutic substance reservoir into a pump chamber of an electromechanical pumping assembly during a first pumping phase,

the plunger being disposed such that therapeutic substance in the pump chamber is in direct contact with the plunger, and

the pump chamber being in fluid communication with the reservoir and not in fluid communication with the subject during the first pumping phase; and

subsequently, delivering the therapeutic substance from the pump chamber to the subject in a plurality of discrete dosages by delivering the therapeutic substance from the pump chamber in a plurality of discrete motions of the plunger during a second pumping phase, the pump chamber being in fluid communication with the subject and not in fluid communication with the reservoir during the second pumping phase,

the method further comprising reducing an amplitude of negative pressure in the pump chamber during a negative-pressure reduction phase between the first pumping phase and the second pumping phase, by maintaining the pump chamber in fluid communication with the reservoir and not in fluid communication with the subject following the drawing of the therapeutic substance into the pump chamber,

wherein maintaining the pump chamber in fluid communication with the reservoir and not in fluid communication with the subject comprises, following the drawing of the therapeutic substance into the pump chamber, using control circuitry to:

(a) maintain open an inlet valve, the inlet valve disposed in a therapeutic substance inlet of the pump chamber through which the therapeutic substance is received from the reservoir into the pump chamber during the first pumping phase, and

(b) maintain closed an outlet valve, the outlet valve disposed in a therapeutic substance outlet of the pump chamber through which the therapeutic substance is delivered from the pump chamber to the subject during the second pumping phase.

2. The method according to claim 1 , wherein:

(a) using the plunger to draw the therapeutic substance from the therapeutic substance reservoir into the pump chamber comprises (i) opening the inlet valve, and (ii) closing the outlet valve, and

(b) delivering the therapeutic substance from the pump chamber to the subject comprises closing the inlet valve and opening the outlet valve.

3. The method according to claim 1 , wherein using the plunger to draw the therapeutic substance from the therapeutic substance reservoir into the pump chamber comprises using the plunger to draw the therapeutic substance from the therapeutic substance reservoir into the pump chamber in a single motion of the plunger.

4. The method according to claim 1 , wherein using the plunger to draw the therapeutic substance from the therapeutic substance reservoir into the pump chamber comprises using the plunger to draw the therapeutic substance from the therapeutic substance reservoir into the pump chamber in one or more discrete expansion motions of the plunger, wherein each expansion motion is longer in duration than any one of the plurality of discrete motions of the plunger during the second pumping phase.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2023
From: EITAN MEDICAL LTD.
To: LTS DEVICE TECHNOLOGIES LTD
Reel/Frame 064757/0626 →
RELEASE OF SECURITY INTEREST Recorded Jun 13, 2023
From: MIZRAHI TEFAHOT BANK LTD.
To: EITAN MEDICAL LTD.
Reel/Frame 063927/0508 →
SECURITY INTEREST Recorded Jun 30, 2022
From: EITAN MEDICAL LTD.
To: MIZRAHI TEFAHOT BANK LTD.
Reel/Frame 060361/0495 →
RELEASE OF SECURITY INTEREST Recorded Jun 23, 2022
From: VIOLA CREDIT FIVE FUND; SHAKED INVESTMENTS (G.P.)
To: EITAN MEDICAL LTD
Reel/Frame 060435/0517 →
MERGER AND CHANGE OF NAME Recorded Oct 28, 2021
From: SORREL MEDICAL LTD.; Q-CORE MEDICAL, LTD.
To: EITAN MEDICAL LTD.
Reel/Frame 057942/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2021
From: ZIDON, SHAHAR; EITAN, BOAZ; BEN-DAVID, ORI; YOSEF, ANDREI
To: SORREL MEDICAL LTD.
Reel/Frame 057116/0267 →
SECURITY INTEREST Recorded Feb 9, 2021
From: SORREL MEDICAL LTD.
To: VIOLA CREDIT FIVE FUND; SHAKED INVESTMENTS (G.P.)
Reel/Frame 055189/0674 →
Continuity (2)
Provisional Application 62425105 · Nov 22, 2016
Related Publication 20190365985A1 · Dec 5, 2019
Cited By (1)
US 12,357,750